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Abstract 
 
    In this study, isoegomaketone(IK) was isolated from Perilla frutescens(L.), a Chinese herbal. The effects of IK 
were examined by cell viability assay, colony formation assay, xenograft tumor assay and western blotting in HCC cells. We 
found that IK inhibited cell viability, and its administration decreased tumor volume and weight profoundly. The presence of 
IK(10nmol/l) produced a dramatic decrease of pAkt, while total Akt level was not affected. The data suggested that IK from 
perilla suppressed HCC tumor growth via blocking PI3K/Akt signaling pathway.  
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Introduction 
 
     Hepatocellular carcinoma(HCC) is the fifth most common cancer and the third leading cause of cancer-related 
death. It is estimated that every year more than 1 million people die of HCC worldwide (Hussain et al., 2009). Many 
signaling molecules involved in proliferation or metastasis are found activated in human HCC specimens. Thus people 
designed drugs targeting activated signaling pathways for the chemotherapy. But in HCC usual treatment, drugs such as first 
generation platinum compounds exhibit severe hepatotoxicity. For the increasing incidence of HCC, it is urgent to develop 
novel target agent and better chemotherapeutic regiment. 
    Perilla frutescens(L.) is a popular herbaceous plant for its pleasant aroma and taste. Its leaves are delicious 
vegetable and seeds are full of oil. It is also a traditional herb in China. Ingredients isolated from Perilla frutescens(L.) such 
as rosmarinic acid, caffeic acid and apigenin have been demonstrated to inhibit cell proliferation in various type of cancers. 
However, there are less reports about the effects of isoegomaketone(IK) on tumor. Cho and his colleagues have found that IK 
exhibited apoptosis-inducing effects on colon cancer cells (Cho et al., 2011), but the effects of IK on other cancer cells and 
the precise mechanism have not been reported.  
     Phosphoinositide 3-kinase(PI3K)-Akt signaling pathway plays a pivotal role in regulating the proliferation, 
apoptosis and metastasis of tumor cells. It is a key juncture in signaling communication network. It makes crosstalk between 
several important pathways, for example, Bcl/Bcl/caspases, AMPK/mTOR/survivin, GSK/ERK/c-fos, p21/p27/cyclin-D1 etc. 
Therefore, the PI3K-Akt signaling network is acknowledged as a potential target for novel agents of chemoprevention and 
chemotherapy. So we detected the change of PI3K/Akt in IK treated HCC cells. The demonstration of the target of IK is 
helpful to disclose the potential molecular mechanism of this novel chemoprevention agent.  
     In this study, we explored the anti-tumor effects of IK separated from Perilla frutescens(L.) on human HCC cells. 
This is the first report about IK inhibiting proliferation via PI3K/Akt signaling pathway in human HCC cells. 
 
Wang et al., Afr J Tradit Complement Altern Med. (2013) 10(2):251-257 
http://dx.doi.org/10.4314/ajtcam.v10i2.9 
252 
Methods 
Extracts preparation 
 
    Perilla Frutescens (voucher No.08045) were purchased from local herb stores in Luoyang City. Voucher specimen 
of plant materials were preserved in the Herbarium at Henan Technology University. The leaves of Perilla Frutescens were 
dried, and extracted in MeOH over 3 days at room temperature. The extract was partitioned by ethyl acetate(EA), butanol and 
water. The EA fraction was separated by a silica gel column using a gradient of hexane-EA. The fraction was further 
segregated to yield IK. The final IK solution was prepared in DMSO. 
 
Cell lines and animals 
 
    Two hepatoma cell carcinoma-derived cell line-Huh-7 and Hep3B were used as experimental materials. Cells were 
cultured in Dulbecco's modified Eagle's medium(Invitrogen) supplemented with 10%(V/V) fetal bovine serum(GIBCO) and 
incubated at 37o C in an atmosphere of 5% CO2. Male BALB/c nude mice(5-6 wk old) were purchased from Experimental 
Animal Center of Henan Technology University. These mice were housed in a windowless room at 22±1 o C. The animal 
experiments were approved by the Ethics Committees of Henan Technology University.  
 
Cell proliferation and colony formation  
 
    Cell viability was examined by Cell Counting Kit-8 (Dojindo) according to the instructions of the manufacturer. 
Huh-7 and Hep3B cells were cultured on 10-cm plate and G418(Invitrogen) (0.6-1mg/ml) screening was done for colony 
formation. 
 
Western blot assay  
 
    Cells were lysed in Laemmli buffer and quantified using bradford assay (Bio-Rad). 20 μg protein was analyzed by 
standard procedures, with antibodies for pAkt (Cell Signaling, 1:1000) and β-tubulin (Sigma, 1:2000). The secondary 
antibodies were goat anti-mouse-HRP and goat anti-rabbit-HRP (IgG; Pierce, 1:3000). Finally, the PVDF membrane was 
washed and detected with ECL substrate solution (GE healthcare). Signals were detected by SyngeneTM gel imaging analysis 
system and quantified by Genetools software. β-tubulin was considered as a loading control. 
 
Tumorigenicity assays and drug administration  
 
    Nude mice were randomized by weight into 2 groups (5 animals/group), and each was injected 2×106 Huh-7 cells 
subcutaneously to establish xenograft animal model. IK(10μM/ml,0.2ml/d) or vehicle(0.1%DMSO) were administrated 
intragastrically to treated group or control group for 8 weeks. Tumor size was measured by calipers, and tumor volume was 
confirmed using following formula: volume=0.5×width2×length. Kinetics of tumor formation was evaluated by keeping the 
records of tumor size/volume change at every 3-day interval.  
 
Xenograft immunohistochemistry staining 
 
    The pAkt immunostaining was carried out on 5 μm sections of formalin fixed paraffin embedded xenograft tumors. 
Antigen retrieval was performed by pretreating the dewaxed and rehydrated slides in 96 o C water bath for 30 minutes in 
sodium citrate buffer(pH 6.0). Sections were cooled at room temperature and incubated in rabbit anti-pAkt Ser473 (1:500, 
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Cell Signaling, Rome, Italy) overnight, followed by PBS washing and incubation with secondary antibody. Immunoreactivity 
was revealed by enhanced immunoperoxidase system (Novocastra, Florence, Italy) and a chromogenic 
substrate-3,3'-diaminobenzidine according to manufacturer's instructions. 
 
Statistical analysis 
 
    All data were presented as Mean±SD. Tumor weight and volume was compared by Mann-Whitney U test. P 
values of <0.05 were considered to be significant. All Statistical analyses were performed using SPSS for windows 16.0. 
 
 
Results and Discussion 
 
     The results obtained in Figure 1 suggested that IK inhibited cellular proliferation and colony formation in Huh-7 
and Hep3B cell lines. After IK addition, the A450 of viable HCC cells decreased and colonies number was significantly 
reduced. 
   
   
Figure 1: IK inhibits the cellular proliferation and colony formation. A, IK suppressed the proliferation of Huh-7 cells. B, IK 
inhibited the colony formation of Huh-7 cells, as shown by representative dishes treated with 10nM IK or 
0.1%DMSO(control). Columns, mean(n=3); bars, SD. C, IK suppressed the proliferation of Hep3B cells. D, IK 
inhibit the colony formation of Hep3B cells. 
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Figure 2: IK inhibits Akt phosphorylation in Huh-7 cells. Western blotting assay for expression of total Akt, Ser 473 pAkt, 
Thr 180 p-p38 MAPK. Protein(20μg/lane) was separated by SDS-PAGE and blotted to PVDF membrane. Protein 
levels were normalized by a loading control-β-tubulin. 
     
The expression level of Akt was examined by western blotting assay. Figure 2 showed that IK decreases pAkt level,  
not MAPK. Our data clearly showed that IK treatment influenced PI3K/Akt signal pathway, not MAPK pathway. 
   As shown in Figure 3 and Figure 4, a decrease of tumor volume and weight indicated that IK suppressed the 
tumorigenicity and reduced tumor burden.  
 
Figure 3: IK treatment decreases the xenograft tumor volume. IK suppressed tumorigenicity of Huh-7 cells in a flank of nude 
mice(n=5). Tumor size was estimated by serial calipation. 
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Figure 4: The weight and immunohistochemistry analysis of xenograft tumors. A. IK treatment decreased the tumor weight. 
Tumor was estimated by analytical balance. The results showed the statistically significant 
difference(Mann-Whitney test; n=5, p<0.01) . B. IHC confirms that pAkt was down-regulated in xenograft tumors 
of IK group.  
  
        There is an old saying in china: Food and medicine have same action. Perilla, a plant genus of the family 
Lamiaceae and it is an ingredient of Banxia Houpu (DRUGS,CHINESE HERBAL). It is an aromatic vegetable which is 
always used as sapid substance in salad or noodles, but it is also commonly known for its anti-oxidant, anti-allergic, 
anti-tumor properties (Zhao et al., 2011; Kim et al., 2005; Makino et al., 2001; Ueda et al., 2002; Makino et al., 2003; Takano 
et al., 2004; Kwak et al., 2009; Banno et al., 2004). 
      In our research, we found one ingredient of perilla-IK inhibited the tumor growth and decreased pAkt level. It 
provided new evidence of the anti-tumor property of perilla and shed light on the molecular mechanism of its action. As we 
all know, Akt is the key protein in PI3K/Akt pathway. Its phosphorylation is the activation step of this pathway. PI3K/Akt is 
very important in the whole signaling network. It is the center of a lot of signal pathways involved in apoptosis, inflammation, 
angiogenesis, metastasis, infiltration and etc.(Yuan et al., 2012; Chen et al., 2012; Kirouac et al., 2012; Blunt et al., 2012; 
Okumura et al., 2012; Tenbaum et al., 2012; Wallin et al., 2012; Chiu et al., 2012; Kim et al., 2012; Cheng et al., 2011). From 
the data obtained in this study, we speculated that IK initiated signaling pathways which are correlated with anti-tumor 
growth via inhibiting Akt phosphorylation. Thus it decreased the volume and weight of xenograft tumor.  
        The anti-cancer effects of perilla provide a beautiful perspective of traditional medicine. It warrants further 
researches on drug development and medicated diet regiment.   
 
Conclusion 
 
      The results in this study indicated that one ingredient of Perilla frutescens(L.)-IK was a potential antitumor agent 
Wang et al., Afr J Tradit Complement Altern Med. (2013) 10(2):251-257 
http://dx.doi.org/10.4314/ajtcam.v10i2.9 
256 
against HCC cells at least partly via PI3K/Akt signaling pathway. IK significantly inhibited cell viability and xenograft tumor 
formation of HCC cells. Our results indicated that Akt phosphorylation was inhibited after IK administration but not Akt or 
p38 expression. This suggested that the mechanism of IK inhibiting HCC growth was related to PI3K/Akt signaling pathway. 
This is the first article about effects of IK on HCC cells, which disclosed the precise functional mechanism of the traditional 
herb-Perilla frutescens(L.). As the relationship between IK and signaling pathways becoming clearer, new therapeutic 
strategies would be further explored and developed.  
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